European Journal of Gastroenterology & Hepatology

Papers
(The H4-Index of European Journal of Gastroenterology & Hepatology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Paper Alert40
Paper alert36
String used for oesophageal capsule endoscopy: help or hindrance?32
Quality of care in inflammatory bowel disease from patient’s perspective using QUOTE-IBD: a Greek multicenter prospective study31
Correlating endoscopic findings with pathology to optimize biopsy strategies in gastritis: insights from a large cohort study26
Mid- to long-term outcomes of initial transjugular intrahepatic portosystemic shunt versus anticoagulation for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome26
Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites24
Comment on ‘Home-based transcutaneous electrical acupuncture-point stimulation for depressive symptoms in inflammatory bowel disease: a randomized feasibility study’23
Prevalence, risk factors, and clinical outcomes of extraintestinal manifestations in inflammatory bowel disease: a population-based study in china22
Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease21
Effectiveness and safety of newly introduced endoscopic submucosal dissection in a Western center: a real-life study20
Fib-4 index predicts prognosis after achievement of sustained virologic response following direct-acting antiviral treatment in patients with hepatitis C virus infection20
Cardiac involvement in Wilson’s disease: a retrospective cohort study18
Endoscopic retrograde cholangiopancreatography discharge tool combined with rapid trypsinogen-2 test to predict same-day discharge: a prospective cohort study18
High sustained virologic response rate after 8 weeks of direct-acting antivirals in cancer patients with chronic hepatitis C virus17
Clinical study of probiotics combined with lactulose for minimal hepatic encephalopathy treatment16
Construction and validation of the predictive model for gallbladder cancer liver metastasis patients: a SEER-based study16
SAFE vs. FIB-4: diagnostic accuracy for clinically significant fibrosis in U.S. adults with cardiometabolic risk factors – a NHANES 2017–2020 analysis16
0.10023212432861